The percent contribution of the mCherry+ AML cells to the human CD45 fraction was significantly reduced in the blood and spleen of the groups that received the shUSP15-mixed population as compared to the shSCR group, despite having comparable representation at the start of the transplant (Figs. 2F and S1C). The gene discussed is PTPRC; the disease is acute myeloid leukemia.